BDBM620535 N-(1-Hydroxy-4-((trifluoromethyl)sulfonyl)-1,3-dihydrobenzo[c][1,2]oxaborole-6-carbonyl)-N-(2-(1-hydroxy-4-((trifluoromethyl)sulfonyl)-1,3-dihydrobenzo-[c][1,2]oxaborole-6-carboxamido)ethyl)glycine::US11767332, Example 42

SMILES OB1OCc2c1cc(cc2S(=O)(=O)C(F)(F)F)C(=O)NCCN(CC(O)=O)C(=O)c1cc2B(O)OCc2c(c1)S(=O)(=O)C(F)(F)F

InChI Key InChIKey=MDVFAWOHRRNTKZ-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 620535   

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620535(N-(1-Hydroxy-4-((trifluoromethyl)sulfonyl)-1,3-dih...)
Affinity DataKd:  1.10E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
Go to US Patent